Welcome to Ruhvenile® Biomedical

We are a DEEP-TECH biomedical company based in New Delhi, India, focused on solving critical challenges across healthcare, life sciences, agriculture, personal care, and environmental health. Built on a strong foundation of rigorous scientific research and advanced technology, we develop high-value products that deliver real-world impact. Trusted by leading institutions in multiple countries across five continents, we empower industries and researchers to drive the future of biomedical technology.

Our Journey of Innovation

2026

Expanding new horizons with global collaborations and breakthroughs.

2025

• Winner of Startup MahaRathi Grand Challenge.
• Top 100 companies by Tata Social Enterprise Challenge.
• Hydrogelator HzO TOR® received INCI approval.
• BiomLife® and truGnom® were recognized in the Atlas of Innovation by The Union, the Gates Foundation, and ICMR for their role in advancing the global mission to End Tuberculosis.

2024

BiomLife® recognized by the Galien Foundation for innovation in public health.

2023

• Internationally recognized again as DEEP TECH PIONEER by Hello Tomorrow, Paris, France.
• Top 8 finalist at the G20 Young Entrepreneurs Alliance (YEA) Summit.
• Selected by Ministry of External Affairs (MEA), Govt. of India for the ELEVATE Pitch in Dubai.

2022

• Internationally recognized as DEEP TECH PIONEER by Hello Tomorrow, Paris, France.
• Honored by UK & Belgium governments as a top Indian startup.
• Winner of National Bio-entrepreneurship Competition (NBEC).

2015

Company was founded and registered.